OBJECTIVE: To determine the frequency and severity of complications that occur as a result
of uterine artery embolization for leiomyomas. METHODS: As part of an ongoing study of …

Objective To evaluate the efficacy of acrylamido polyvinyl alcohol microspheres (a-PVAM)
as an embolic agent for uterine artery embolization (UAE) compared with Tris-acryl gelatin …

OBJECTIVE: To determine the long-term outcome from uterine artery embolization for
leiomyomata. METHODS: In a prospective study, 200 consecutive patients treated with …

Objective. To examine the sonographic and angiographic imaging findings before and after
uterine fibroid embolization for symptomatic leiomyoma. Methods. This prospective study …

The first reported use of transcatheter arterial embolization in the management of intractable
bleeding related to pelvic trauma appeared in the literature in 1973. Other indications for …

Purpose To assess the efficacy of two embolic agents in the treatment of symptomatic
uterine leiomyomas. Materials and Methods A randomized, prospective, single-center study …

Uterine fibroids (leiomyomas) are the most common benign neoplasm of the female pelvis
and have a lifetime prevalence exceeding 80% among African American women and …

PURPOSE: To assess the feasibility of performing uterine artery embolization as an
outpatient treatment for symptomatic uterine fibroids. MATERIALS AND METHODS: Forty …

PURPOSE: To determine whether the severity of postprocedure pain associated with uterine
artery embolization (UAE) for leiomyomata can be predicted and if its severity can predict …

Purpose To study the factors that might impact infarction of individual uterine leiomyomas
and total tumor burden after uterine artery embolization (UAE). Materials and Methods This …